Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Asymmetric Targeted DBS for PD With PIGD

NCT: NCT05397340 · COMPLETED

NCT IDNCT05397340
StatusCOMPLETED
Start Date2022-09-01
Completion2025-11-03
SponsorRuijin Hospital (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to compare the effectiveness of the deep brain stimulation of asymmetric targets \[subthalamic nucleus (STN) in the right hemisphere while globus pallidus interna (GPi) in the left\] versus the bilateral STN for the treatment of Parkinson's disease (PD) with postural instability/gait difficulty (PIGD) in a randomized, double-blinded manner.

Frequently Asked Questions

What is Asymmetric Targeted DBS for PD With PIGD?

Asymmetric Targeted DBS for PD With PIGD is a clinical trial registered under NCT05397340. Current status: COMPLETED.

What is the status of NCT05397340?

The current status of NCT05397340 (Asymmetric Targeted DBS for PD With PIGD) is: COMPLETED.

When did Asymmetric Targeted DBS for PD With PIGD start?

Asymmetric Targeted DBS for PD With PIGD started on 2022-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.